The Administration’s intent to curtail the ability of pharmacy benefit managers to negotiate lower drug prices will do nothing to reduce the high costs of prescription drugs.
Abolishing Drug Rebates May Push Consumer Drug Costs Higher
The Administration’s intent to curtail the ability of pharmacy benefit managers to negotiate lower drug prices will do nothing to reduce the high costs of prescription drugs.